Cassaday & Co Wealth Management’s Bio-Techne TECH Stock Holding History

Cassaday & Co Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.5K	Hold	700	–	–	﹤0.01%	625
2026 Q1	$36.6K	Buy	+700	New	+$42K	﹤0.01%	675

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cassaday & Co Wealth Management's TECH Position: Q2 2026 in Review

Cassaday & Co Wealth Management held its Bio-Techne (TECH) position steady in Q2 2026 at 700 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #625.

Cassaday & Co Wealth Management first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Cassaday & Co Wealth Management held 700 shares of Bio-Techne worth $49.5K as of Q2 2026.
Cassaday & Co Wealth Management left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #625 holding.
Cassaday & Co Wealth Management first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.